Sponsor:
University of Florida
Code:
NCT06389591
Conditions
Recurrent Glioblastoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
pp65 RNA loaded lipid particles, pp65 RNA-LPs (Drug Product 1 or DP1)
RNA loaded lipid particles, RNA-LPs (Drug Product 2 or DP2)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-30. This information was provided to ClinicalTrials.gov by University of Florida on 2025-03-25.